期刊文献+

Kupffer细胞在非酒精性脂肪肝病中的作用 被引量:2

The role of Kupffer cells in nonalcoholic fatty liver disease
原文传递
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease, NAFLD)是一种无过量饮酒史、以肝细胞脂肪变性和脂肪贮积为特征的临床病理综合征。Kupffer细胞是位于肝脏中的特殊巨噬细胞,是先天免疫中的重要组成部分,在肝脏疾病中起关键作用。多项研究表明,Kupffer细胞在NAFLD的发生发展过程中起重要作用。本文总结了Kuffer细胞在NAFLD疾病发生发展中的多重作用,旨在为NAFLD的治疗提供一个有效的靶点。 Non-alcoholic fatty liver disease(NAFLD)is a clinical pathological syndrome characterized by no history of excessive drinking,hepatic steatosis and fat accumulation.Kupffer cells,special macrophages located in the liver,are an important component of innate immunity and play a key role in liver disease.In recent years,several studies have shown that Kupffer cells play an important role in the development of NAFLD.This review summarizes the multiple roles of Kuffer cells in the development of NAFLD,aiming to provide an effective target for the treatment of NAFLD.
作者 徐芳芷 熊令伊 万敬员 杨森 XU Fangzhi;XIONG Lingyi;WAN Jingyuan;YANG Sen(Chongqing Key Lab of Biochemistry and Molecular Pharmacology,Chongqing Medical University,Chongqing 400016,China)
出处 《生命的化学》 CAS CSCD 2019年第3期464-471,共8页 Chemistry of Life
基金 国家自然科学基金项目(81774124,81373870)
关键词 非酒精性脂肪肝病(NAFLD) KUPFFER细胞 脂质堆积 氧化应激 炎症反应 non-alcoholic fatty liver disease(NAFLD) Kupffer cells lipid accumulation oxidative stress inflammation
  • 相关文献

参考文献3

二级参考文献20

  • 1Raffi Karagozian,Zoltán Derdák,Gy?rgy Baffy.Obesity-associated mechanisms of hepatocarcinogenesis[J]. Metabolism . 2014
  • 2Bernd Schnabl,David A. Brenner.Interactions Between the Intestinal Microbiome and Liver Diseases[J]. Gastroenterology . 2014
  • 3Samuel Buck S,Shaito Abdullah,Motoike Toshiyuki,Rey Federico E,Backhed Fredrik,Manchester Jill K,Hammer Robert E,Williams S Clay,Crowley Jan,Yanagisawa Masashi,Gordon Jeffrey I.Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 4L. K. Brahe,A. Astrup,L. H. Larsen.Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases?[J]. Obes Rev . 2013 (12)
  • 5Diego Rincón,Javier Vaquero,Ana Hernando,Evelyn Galindo,Cristina Ripoll,Marta Puerto,Magdalena Salcedo,Rubén Francés,Ana Matilla,María V. Catalina,Gerardo Clemente,José Such,Rafael Ba?ares.Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites[J]. Liver Int . 2014 (10)
  • 6Manish Kumar Lunia,Barjesh Chander Sharma,Praveen Sharma,Sanjeev Sachdeva,Siddharth Srivastava.Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial[J]. Clinical Gastroenterology and Hepatology . 2014
  • 7Reiner Wiest,Melissa Lawson,Markus Geuking.Pathological bacterial translocation in liver cirrhosis[J]. Journal of Hepatology . 2014 (1)
  • 8Gyongyi Szabo.Gut–Liver Axis in Alcoholic Liver Disease[J]. Gastroenterology . 2014
  • 9S.M. O’Mahony,G. Clarke,Y.E. Borre,T.G. Dinan,J.F. Cryan.Serotonin, tryptophan metabolism and the brain-gut-microbiome axis[J]. Behavioural Brain Research . 2014
  • 10Graham J. Dockray.Gastrointestinal hormones and the dialogue between gut and brain[J]. J Physiol . 2014 (14)

共引文献92

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部